Journals / Kardiyovasküler Hemşirelik Dergisi / 2019 / Cilt: 10 - Sayı: 21

Pulmonary Hypertensıon and Nursıng Care

Pulmoner Hipertansiyon ve Hemşirelik Bakımı

Pages
17–24
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this rewiev was discussed in order to present etiology, classification, pathophysiology, treatment and care of pulmonary hypertension.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pulmonary hypertension is a progressive destructive disease characterized by vascular changes.
📊
Key Findings & Data:The aim of treatment and care of the patients is to decrease morbidity and mortality and to heal symptoms and functional situation.
💡
Conclusion & Impact:In this rewiev was discussed in order to present etiology, classification, pathophysiology, treatment and care of pulmonary hypertension.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Pulmonary hypertension is a progressive destructive disease characterized by vascular changes. Proliferation and vasoconstriction of pulmonary arteries lead to right heart failure and death. While patients usually have symptoms, such as dyspnea, fatigue, weakness and edema, at the beginning, the syncope and presyncope can be observed in late periods. The mentioned symptoms imitate other cardio-pulmonary diseases and a delay occurs in establishing a diagnosis in patients with pulmonary hypertension. Pulmonary hypertension is a chronic disease, restricts the daily life and the patients face with many symptoms which reduce quality of life. All of the current medical treatments and cares of the patients are complicated and are largely palliative. The aim of treatment and care of the patients is to decrease morbidity and mortality and to heal symptoms and functional situation. Frequent hospitalization occurs in pulmonary hypertension cases. Nurses should know the high risk-bearing patient groups in terms of pulmonary hypertension. Nurses have important roles in training of patients and patient relatives, care of patients, administration of medical treatment, symptom management and patient follow-up in pulmonary hypertension. In this rewiev was discussed in order to present etiology, classification, pathophysiology, treatment and care of pulmonary hypertension.

Özet

Pulmoner hipertansiyon vasküler değişiklikler ile karakterize ilerleyici bir hastalıktır. Pulmoner arterlerin proliferasyonuve vazokonstriksiyonu sağ kalp yetersizliğine ve ölüme yol açmaktadır. Hastalar genellikle başlangıçta nefes darlığı, halsizlik, yorgunluk ve ödem gibi semptomlar deneyimlerken geç dönemlerinde senkop, presenkop görülebilmektedir. Busemptomlar diğer kardiyopulmoner hastalıkları taklit etmekte ve pulmoner hipertansiyonlu hastalarda tanı koymadagecikme olmaktadır. Pulmoner hipertansiyon kronik bir hastalık olup, günlük yaşamı sınırlamakta ve hastalar yaşamkalitesini azaltan birçok semptomla karşı karşıya kalmaktadır. Mevcut tüm medikal tedavi ve bakım karmaşık olupbüyük oranda palyatiftir. Tedavinin ve bakımın amacı; morbidite ve mortaliteyi azaltmak, semptomları ve fonksiyoneldurumu iyileştirmektir. Pulmoner hipertansiyon vakalarında hastaneye sık yatışlar olmaktadır. Hemşireler; pulmonerhipertansiyon açısından yüksek risk taşıyan hasta gruplarını bilmelidir. Hemşireler pulmoner hipertansiyonda hasta vehasta yakınlarının eğitiminde, hasta bakımında, medikal tedavinin uygulanmasında, semptom yönetiminde ve hastatakibinde önemli rollere sahiptir. Bu makale pulmoner hipertansiyonun etiyolojisi, sınıflandırılması, patofizyolojisi, tedavi ve bakımını sunmak amacıyla yazıldı.

🔖

Cite This Article

ÖZDEMİR, Ö., ÜNSAR, S., BULUT, E. Y. (2022). Pulmonary Hypertensıon and Nursıng Care. Kardiyovasküler Hemşirelik Dergisi, Cilt: 10 - Sayı: 21, 17–24. https://ajindex.com/articles/571187

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Öztürk Ö, Şahin Ü. Pulmoner Arteriyel Hipertansiyon: Tanı ve Tedavisi. Süleyman Demirel Üniversitesi Tıp Fakültesi Dergisi 2009;16:39–47
  2. Purcell HJ, Kalra PR. Pulmoner Hipertansiyon. In: İlerigelen B. çev. Kardiyoloji
  3. Baskı. İstanbul: İstanbul Tıp Kitabevi; 2009. s. 276–86
  4. Peacock AJ, Murphy NF, McMurray JJ, Caballero L, Stewart S. An epidemiological study of pulmonary arterial hypertension. Eur Respir J 2007;30:104–9
  5. McGoon MD, Benza RL, Escribano-Subias P, Jiang X, Miller DP, Peacock AJ, et al. Pulmonary arterial hypertension: epidemiology and registries. [Article in Turkish]. Turk Kardiyol Dern Ars 2014;42 Suppl 1:67–77
  6. McGoon MD, Miller DP. REVEAL: a contemporary US pulmonary arterial hypertension registry. Eur Respir Rev 2012;21:8–18
  7. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006;173:1023–30
  8. Pektaş MB, Pektaş A, Emren SV, Aldemir M, Özkeçeci G, Kula S, et al. An Epidemiological Study of Pulmonary Hypertension In Turkish Adults. Mustafa Kemal Üniversitesi Tıp Dergisi 2015;6(:24–31
  9. Housten-Harris T. The nurse specialist and practical issues in the care of pulmonaryarterial hypertension patients. Int J Clin Pract Suppl 2007;61:10–8
  10. Wapner J, Matura LA. An Update on Pulmonary Arterial Hypertension. J Nurse Pract 2015;11:551–9
  11. Wilkens H, Grimminger F, Hoeper M, Stähler G, Ehlken B, Plesnila-Frank C, et al. Burden of pulmonary arterial hypertension in Germany. Respir Med 2010;104:902–10
  12. Taichman DB, Shin J, Hud L, Archer-Chicko C, Kaplan S, Sager JS, et al. Health-related quality of life in patients with pulmonary arterial hypertension. Respir Res 2005;6:92
  13. Kukkonen M, Puhakka A, Halme M. Quality of life among pulmonary hypertension patients in Finland. Eur Clin Respir J 2016;3:26405
  14. Poms A, Kingman M. Inhaled treprostinil for the treatment of pulmonary arterial hypertension. Crit Care Nurse 2011;31:e1–10
  15. Kaymaz C, Mutlu B, Küçükoğlu MS, Kaya B, Akdeniz B, Kılıçkıran Avcı B, et al. Preliminary results from a nationwide adult cardiology perspective for pulmonary hypertension: RegiStry on clInical outcoMe and sUrvival in pulmonaRy hypertension Groups (SIMURG). Anatol J Cardiol 2017;18:242–50
  16. Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al; Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiolog